Analgesics
Which will be the fastest growing segment within the analgesics market this year? Which company accounted for the largest share of the UK analgesics market last year? What are the key distribution channels in the United States? Which is the leading country for analgesics in emerging economies?
The answers to these – and many more – market questions can be found in the reports, books, and subscriptions listed under Research and Markets’ Analgesics category. Our publications provide expert
... more
Sort by
-
Analgesics in Latvia
Euromonitor International, Apr 2013 , Pages: 24Improving purchasing power changed customers’ preferences for analgesics in 2012. The customers not only bought more packaging but also chose more expensive products that were considered to be less... -
Analgesics in Lithuania
Euromonitor International, Apr 2013 , Pages: 25A slight rebound of the overall consumer health industry drove the rebound of analgesics. The category is a lot more stable compared to other OTC categories, with little innovation brewing in laboratories... -
Analgesics in Uzbekistan
Euromonitor International, Apr 2013 , Pages: 21Towards the end of the review period, analgesics continued to be one of the biggest and most dynamic categories in OTC products in Uzbekistan, as the third biggest category in current value terms. Analgesics... -
Analgesics in Algeria
Euromonitor International, Apr 2013 , Pages: 24Analgesics witnessed a solid 9% value growth in 2012, resulting from stronger demand in all categories, and more particularly, paediatric analgesics. The introduction of social security card Chifa was... -
Analgesics in Finland
Euromonitor International, Apr 2013 , Pages: 38Analgesics increased by 2% in current value terms in 2012, reaching €81 million. Despite the category being mature, positive sales were achieved by the launch of new products, new formats and new sizes... -
Analgesics in Kazakhstan
Euromonitor International, Apr 2013 , Pages: 22Towards the end of review period, analgesics was driven by the stressful and hectic lifestyle of many Kazakh consumers, particularly urban citizens, which supported the increasing demand for analgesics.... -
Analgesics in Sweden
Euromonitor International, Apr 2013 , Pages: 31Consumers are increasingly treating their own minor ailments and complaints instead of visiting healthcare professionals. The growing self-medication trend in Sweden benefits sales of analgesics and... -
Analgesics in Greece
Euromonitor International, Apr 2013 , Pages: 27The grim economic situation in Greece, with disposable income shrinking at unprecedented levels, did not leave the category of analgesics unaffected. Despite the self-medication trend which tends to... -
Analgesics in Poland
Euromonitor International, Apr 2013 , Pages: 34Increasingly hectic lifestyles in Poland make more consumers suffer from stress and various aches. Many people perform stressful jobs, working long hours and allowing little or no time for balanced... -
Analgesics in Azerbaijan
Euromonitor International, Apr 2013 , Pages: 21The retailers are expanding their presence in healthcare, with an increasing number of chains amongst which Zafaran Apteki is in the lead. Besides, the number of new clinics and hospitals also is increasing.... -
Analgesics in China
Euromonitor International, Apr 2013 , Pages: 46Retail sales of analgesics increased by 10% to reach RMB6.2 billion in 2012. This dynamic growth came from increasing awareness of self-medication among Chinese consumers, who are visiting chemists/pharmacies... -
Analgesics in Chile
Euromonitor International, Apr 2013 , Pages: 33Analgesics current value sales recovered after declining by 8% experienced in 2010 and marginal growth in 1% in 2011 due to the incidence of influenza A (H1N1). Growth experienced after 2010 could be... -
Analgesics in Uruguay
Euromonitor International, Mar 2013 , Pages: 21Consumers’ preference for non-steroidal anti-inflammatory drugs (NSAIDs) for fast relief of pain of different aetiology, with little or no unwanted side effects has been addressed by companies for many... -
Analgesics in Venezuela
Euromonitor International, Mar 2013 , Pages: 33Selected consumer health brands – including some analgesics- have had static prices since 2003 as a result of strict price control imposed by the Venezuelan government. Since accumulated inflation reached... -
Analgesics in Australia
Euromonitor International, Mar 2013 , Pages: 30Arthritis was a key driver of sales within analgesics in 2012. A report by Access Economics found that 3.85 million Australians suffer with a form of arthritis, with the figure expected to double by... -
Analgesics in Croatia
Euromonitor International, Mar 2013 , Pages: 23Analgesics are amongst the most heavily advertised OTC products. Modern lifestyles bring additional stress and have a negative effect on health; often manifested in the form of pain. Companies are aware... -
Analgesics in Mexico
Euromonitor International, Feb 2013 , Pages: 44The analgesics category is relatively stable, with the majority of sales held by the largest and most established brands. As a result, brands seek to differentiate themselves not only through extensive... -
Analgesics in the United Arab Emirates
Euromonitor International, Feb 2013 , Pages: 23OTC analgesics continued to face strong competition from Rx alternatives in the United Arab Emirates at the end of the review period. Many chemists/pharmacies reportedly offer higher-strength Rx products... -
Analgesics in Saudi Arabia
Euromonitor International, Nov 2012 , Pages: 32While Saudi Arabia has a strong legislative framework for the classification of OTC and Rx medicines, UTC sales of Rx medicines are widely available. If a consumer requests a brand of Rx analgesics... -
Analgesics in Egypt
Euromonitor International, Nov 2012 , Pages: 17There are no OTC analgesics available in Egypt for legal sale without a prescription. All analgesics are classified as Rx medicines in the country and are thus excluded from the scope of this research. Euromonitor... -
Analgesics in Slovenia
Euromonitor International, Oct 2012 , Pages: 29The growth in 2011 was two percentage points lower than the growth in 2010. This was mainly caused by a significant decline in the growth of Bayer Aspirin and Lekadol (acetaminophen). Euromonitor International's... -
Disease and Therapy Review: Migraine
Timely Data Resources, Inc, Sep 2012 , Pages: 13The Migraine Disease and Therapy Review provides an overview of the disease and related conditions, with prevalence numbers and percentages for major countries worldwide, information on diagnosis, and... -
Analgesics in Kenya
Euromonitor International, Sep 2012 , Pages: 23The analgesics market has grown by 8% from KES6.6 billion in 2010 to KES7.1 billion in 2011. Growth is, however, expected to slow in the coming years as the weakening shilling threatens to raise fuel... -
Analgesics in Pakistan
Euromonitor International, Sep 2012 , Pages: 19The onset of dengue fever during 2011 resulted in increased demand for analgesics during 2011, as it was the most widely recommended medication for sufferers. Consumers who suffered from fever were... -
Analgesics in Portugal
Euromonitor International, Sep 2012 , Pages: 27Due to minimal product development and stagnant prices, analgesics in Portugal recorded retail value growth of 2% in 2011. This slow growth could also be attributed to the effects of the economic recession.... -
09 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities
Life Science Intelligence, Sep 2012This report includes details on 30 emerging medical technology companies that have been identified by LSI's in-house research team in September 2012 All companies include technology, market(s), key... -
Analgesics in Vietnam
Euromonitor International, Aug 2012 , Pages: 27In the context of review period, the global climate change negatively affected the weather in Vietnam. For example, northern parts of the country experienced hotter summers and colder winters, whilst... -
Analgesics in South Korea
Euromonitor International, Aug 2012 , Pages: 36During July 2011, many OTC products became available through grocery retail channels in South Korea for the first time. The categories which were benefited from this include digestive remedies and topical... -
Analgesics in Iran
Euromonitor International, Aug 2012 , Pages: 26Due to the widespread consumption of RX analgesics products without prescription, consumption of analgesics is estimated to be much higher than the data projected in Euromonitor database (Euromonitor... -
Analgesics in the Netherlands
Euromonitor International, Aug 2012 , Pages: 26Current value sales of analgesics were positive in 2011 but marginally lower than 2010. Analgesics sales were impacted by changes in distribution legislation introduced during the second half of 2010... -
Analgesics in Morocco
Euromonitor International, Jul 2012 , Pages: 36The number of consumers switching to products that are perceived as being safer and as having fewer side effects continued to increase within systemic analgesics during 2011. According to trade sources,... -
Analgesics in Serbia
Euromonitor International, Jul 2012 , Pages: 25In Serbia, analgesics are considered as widely accepted and very risk-free OTC products which are able to treat a wide range of mild pain and other health problems. Due to such status amongst consumers,... -
Analgesics in Austria
Euromonitor International, Jul 2012 , Pages: 31The category of analgesics was influenced by two important factors in 2011. Firstly, the strong flu season in Austria towards the end of 2010 led to increased consumption of analgesics. Within this,... -
Analgesics in Nigeria
Euromonitor International, Jul 2012 , Pages: 30Analgesics remains one of the most popular forms of OTC in Nigeria only next to cough, cold and allergy (hay fever) remedies. Analgesics are seen by most Nigerians as on the go first aid remedies and... -
Analgesics in Germany
Euromonitor International, Jul 2012 , Pages: 41As in previous years, within overall retail value sales of analgesics, a trend away from systemic towards topical was seen in Germany in 2011. There were many factors behind the overall decline in systemic... -
Analgesics in Italy
Euromonitor International, Jul 2012 , Pages: 43Sales of analgesics continued to decline in 2011. This was due to consumers switching to Rx products such as Oki, Aulin and Nimesulide. Despite warnings of the side-effects of Rx analgesics, Italians... -
Analgesics in Hungary
Euromonitor International, Jul 2012 , Pages: 37Market growth of analgesics in 2011 was significantly affected by switch decision made in September 2010. Topical analgesics with the active ingredient of ketoprofen were switched from OTC to Rx. Although... -
Analgesics in the Philippines
Euromonitor International, Jun 2012 , Pages: 30The increasing preference for more potent and faster acting analgesics continued in 2011, due to the increasing number of Filipinos living fast-paced lifestyles. Growing demand for these types of medications... -
Analgesics in Switzerland
Euromonitor International, Jun 2012 , Pages: 37Demand for analgesics in Switzerland continued to rise during 2011 as a result of busier lifestyles and rising stress levels, a situation which is leading to higher numbers of Swiss people suffering... -
Analgesics in Norway
Euromonitor International, Jun 2012 , Pages: 36The Norwegian Medicines Agency continues to liberalise retailing of OTC medicines in Norway. The list of medicines permitted to be sold in mass retail outlets expanded after liberalisation. The government... -
Analgesics in India
Euromonitor International, Jun 2012 , Pages: 38Self-medication remained on the rise in 2011. Despite being informed regarding the dangers of overuse of systemic analgesics, consumers continued to use OTC products for mild pains. Media promotions... -
Analgesics in the United Kingdom
Euromonitor International, Jun 2012 , Pages: 36Retail value sales of analgesics in the UK declined marginally in 2011, to £518 million. The overall category continues to suffer in value terms from the growth of private label. Consumers are becoming... -
Analgesics in Ireland
Euromonitor International, Jun 2012 , Pages: 38August 2010 saw the Pharmacy Society of Ireland (PSI) introduce guidelines which restricted the display and sale of codeine-based products in pharmacies in Ireland with window displays prohibited and... -
Analgesics in Costa Rica
Euromonitor International, Jun 2012 , Pages: 21Non-steroidal anti-inflammatories (NSAIDs) continue gaining popularity as analgesic options in Costa Rica. As a consequence of on-going free trade agreements, the proliferation of imported brands from... -
Analgesics in Belgium
Euromonitor International, Jun 2012 , Pages: 35Industry consensus was that the end of 2010 and 2011 were atypically dynamic in terms of innovation. Novelties were interesting, including notably Dafalgan Agrume Effervescent, smaller variants of Dafalgan.... -
Analgesics in Singapore
Euromonitor International, Jun 2012 , Pages: 25Analgesics increased by 6% in 2011, reaching S$38 million. Compared with 2010, when analgesics saw 5% growth, this positive growth in 2011 was reflective of buoyant consumer demand, new product launches... -
06 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities
Life Science Intelligence, Jun 2012 , Pages: 40This report includes details on 39 emerging medical technology companies that have been identified by LSI's in-house research team in June 2012 All companies include technology, market(s), key executive,... -
Analgesics in Georgia
Euromonitor International, May 2012 , Pages: 24Two major retail pharmacy leaders of Georgia – PSP Group and Aversi-Pharma Ltd constantly expanded their networks of chemists/pharmacies over the review period. These retailers also expand their presence... -
Analgesics in Thailand
Euromonitor International, May 2012 , Pages: 31Analgesics grew relatively well in 2011 with current value growth of 7%. Catastrophic events and relevant stress were the most overwhelming factors that prompted consumers to seek relief from analgesics.... -
Analgesics in Macedonia
Euromonitor International, May 2012 , Pages: 23Analgesics benefited from growing consumer confidence in self-medication towards the end of the review period. This confidence was partly due to general trends. Stronger media consumer health coverage...
All rights reserved. © Copyright 2013 Research and Markets WWW4
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
